{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:24:45Z","timestamp":1759883085473,"version":"build-2065373602"},"reference-count":18,"publisher":"BMJ","issue":"19","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1136\/heartjnl-2020-317486","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T17:26:08Z","timestamp":1596648368000},"page":"1461-1462","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Observational data during the COVID-19 pandemic: opportunity with uncertainty"],"prefix":"10.1136","volume":"106","author":[{"given":"Sam","family":"Straw","sequence":"first","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-7105","authenticated-orcid":false,"given":"Klaus K","family":"Witte","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"2025100707532664000_106.19.1461.1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317393"},{"key":"2025100707532664000_106.19.1461.2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2025100707532664000_106.19.1461.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20\u2009133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"2025100707532664000_106.19.1461.4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(20)30922-3","article-title":"Ethnicity and COVID-19: an urgent public health research priority","volume":"395","author":"Pareek","year":"2020","journal-title":"Lancet"},{"key":"2025100707532664000_106.19.1461.5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme Inhibitors\/Angiotensin receptor blockers have a biphasic effect?","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025100707532664000_106.19.1461.6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2025100707532664000_106.19.1461.7","doi-asserted-by":"crossref","unstructured":"Mehra MR , Desai SS , Kuy S , et al . Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020.","DOI":"10.1056\/NEJMoa2007621"},{"key":"2025100707532664000_106.19.1461.8","doi-asserted-by":"crossref","unstructured":"Mehra MR , Desai SS , Ruschitzka F , et al . Retracted: hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet 2020.doi:10.1016\/S0140-6736(20)31180-6","DOI":"10.1016\/S0140-6736(20)31180-6"},{"key":"2025100707532664000_106.19.1461.9","unstructured":"Guan WJ , ZY N , Hu Y , et al . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020."},{"key":"2025100707532664000_106.19.1461.10","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.9252","article-title":"Translating science on COVID-19 to improve clinical care and support the public health response","author":"Del Rio","year":"2020","journal-title":"JAMA"},{"key":"2025100707532664000_106.19.1461.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020738","article-title":"Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study","volume":"8","author":"Kontopantelis","year":"2018","journal-title":"BMJ Open"},{"key":"2025100707532664000_106.19.1461.12","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"2025100707532664000_106.19.1461.13","doi-asserted-by":"crossref","unstructured":"Mehta N , Kalra A , Nowacki AS , et al . Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020.doi:10.1001\/jamacardio.2020.1855","DOI":"10.1001\/jamacardio.2020.1855"},{"key":"2025100707532664000_106.19.1461.14","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15572","article-title":"Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension:A Meta-Analysis","author":"Guo","year":"2020","journal-title":"Hypertension"},{"key":"2025100707532664000_106.19.1461.15","doi-asserted-by":"crossref","unstructured":"Barron EBC , Kar P , et al . Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study 2020.","DOI":"10.2139\/ssrn.3605225"},{"key":"2025100707532664000_106.19.1461.16","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6548","article-title":"COVID-19 and African Americans","author":"Yancy","year":"2020","journal-title":"JAMA"},{"key":"2025100707532664000_106.19.1461.17","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.287.21.2765","article-title":"Poor-Quality medical research: what can journals do?","volume":"287","author":"Altman","year":"2002","journal-title":"JAMA"},{"key":"2025100707532664000_106.19.1461.18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bmj.308.6924.283","article-title":"The scandal of poor medical research","volume":"308","author":"Altman","year":"1994","journal-title":"BMJ"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2020-317486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:53:39Z","timestamp":1759848819000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2020-317486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":18,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020,9,14]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/heartjnl-2020-317486"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2020-317486","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}